Recent Updates
Third-Generation Aromatase Inhibitors (Anastrozole; Exemestane; Letrozole): Risk of Tendon Disorders
GUIDELINE ON APPLICATION OF MANUFACTURER’S, IMPORT AND WHOLESALER’S LICENSES FOR REGISTERED PRODUCTS
Kenyataan Media Pengarah NPRA 7 November 2022 Pelancaran Minggu Keselamatan Ubat #MedSafetyWeek 2022
Kenyataan Media KPK 23 Ogos 2022 – Makluman Produk Kosmetik Yang Dikesan Mengandungi Racun Berjadual
Sulfamethoxazole & Trimethoprim (Co-Trimoxazole): Risk of Acute Respiratory Distress Syndrome (ARDS)
KENYATAAN AKHBAR KPK 23 Oktober 2020-Produk-Produk Kosmetik Yang Dikesan Mengandungi Racun Berjadual
Pekeliling berkenaan pelaksanaan Guidelines on Abridged Registration Pathway for Veterinary Products
Kenyataan Akhbar KPK 15 Julai 2020 – Produk-Produk Kosmetik Yang Dikesan Mengandungi Racun Berjadual
Tapentadol: Risk of seizures and reports of serotonin syndrome when co-administered with other drugs
Kenyataan Akhbar KPK 11 April 2017 : Produk-Produk Kosmetik Yang Dikesan Mengandungi Racun Berjadual
Seminar: ASEAN Common Technical Dossier (ACTD) Preparation:Generic Products for Malaysian Submission
Direktif untuk penilaian laporan pemeriksaan pusat kajian biokeuivalens (BE) bagi pendaftaran produk
NPRA mission is to safeguard the nation’s health through scientific excellence in the regulatory control of medicinal products and cosmetics.
COVID-19
As NPRA's mission is to safeguard the nation's health, NPRA has kept up to date with current situations and provide guidance during this period.
PRODUCT SEARCH
Check product status including pharmaceutical, natural & cosmetic products.
REPORTING OF SIDE EFFECTS TO MEDICINES OR VACCINES
To report a suspected side effect or adverse drug reaction (ADR) to any medicine or vaccine
25 Jun 2024; 08:00AM - 05:00PM MOPI Training 2024: Process Validation and application of Statistics in Validation |
11 Jun 2024; 08:00AM - 05:00PM MOPI Training 2024: Computer Systems for Regulated Environment |
15 May 2024; 08:30AM - 01:00PM [INVITATION] SEMINAR: ISPE Online GDP Seminar : Module 2 (Validation & Self-Inspection Requirement for GDP Compliance) |
07 May 2024; 08:00AM - 05:00PM MOPI Training 2024: |
23 Apr 2024; 08:00AM - 05:00PM MOPI Training 2024: Deviations and Investigation Management- How to ensure CAPA Efficiency |